Literature DB >> 26715222

Renal Cancer in the Elderly.

Tania González León1, Maricela Morera Pérez2.   

Abstract

The increase of the aging population corresponds with the rise of renal cancer in elderly patients. The distinction between functional and chronological age, quality of life, and survival estimate are important issues, among others, that should be considered in the management of renal cancer in elderly patients. We made this review with the purpose of synthesizing the most updated criteria regarding indications and outcomes of the different therapeutic options in the management of elderly patients with renal cancer, beginning from the physiologic considerations that characterize them, their capacity to tolerate different therapeutic possibilities, and the prognosis of the patients' risks and comorbidity assessment.

Entities:  

Keywords:  Ablative therapies; Active surveillance; Elderly; Partial nephrectomy; Renal cancer; Renal cell carcinoma

Mesh:

Year:  2016        PMID: 26715222     DOI: 10.1007/s11934-015-0562-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  66 in total

1.  Small renal mass management in the elderly and the calibration of risk.

Authors:  Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Urol Oncol       Date:  2015-04-07       Impact factor: 3.498

2.  Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.

Authors:  Brian R Lane; Robert Abouassaly; Tianming Gao; Christopher J Weight; Adrian V Hernandez; Benjamin T Larson; Jihad H Kaouk; Inderbir S Gill; Steven C Campbell
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

3.  Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: a retrospective study on preoperative prognostic factors.

Authors:  Elena Brassart; Souhil Lebdai; Julien Berger; Sory Traore; Jean-Christophe Bernhard; Tarek Fardoun; Guillaume Muller; Jean-Jacques Patard; Abdel Rahmène Azzouzi; Pierre Bigot
Journal:  Int J Urol       Date:  2012-03-27       Impact factor: 3.369

4.  Understanding criteria for surveillance of patients with a small renal mass.

Authors:  Bruce L Jacobs; Hung-Jui Tan; Jeffrey S Montgomery; Alon Z Weizer; David P Wood; David C Miller; J Stuart Wolf; Khaled S Hafez
Journal:  Urology       Date:  2012-05       Impact factor: 2.649

Review 5.  Renal cancer surgery in the elderly.

Authors:  Frederik C Roos; Christian Hampel; Joachim W Thüroff
Journal:  Curr Opin Urol       Date:  2009-09       Impact factor: 2.309

Review 6.  Active surveillance for small renal tumors: have clinical concerns been addressed so far?

Authors:  Paolo Gontero; Steven Joniau; Marco Oderda; Mirja Ruutu; Hein Van Poppel; M Pilar Laguna; Jean de la Rosette; Ziya Kirkali
Journal:  Int J Urol       Date:  2012-11-06       Impact factor: 3.369

Review 7.  The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG Taskforce.

Authors:  Joaquim Bellmunt; Sylvie Négrier; Bernard Escudier; Ahmad Awada; Matti Aapro
Journal:  Crit Rev Oncol Hematol       Date:  2008-09-05       Impact factor: 6.312

8.  Renal preservation therapy for renal cell carcinoma.

Authors:  Yichun Chiu; Allen W Chiu
Journal:  Int J Surg Oncol       Date:  2012-08-23

9.  Management of renal cell carcinoma presenting as inflammatory renal mass.

Authors:  Ehab Eltahawy; Mohamed Kamel; Mahmoud Ezzet
Journal:  Urol Ann       Date:  2015 Jul-Sep

10.  Predictors of postoperative renal functional damage after nephron-sparing surgery.

Authors:  Jun Qi; Yongjiang Yu; Tao Huang; Qiang Bai; Jian Kang; Junhao Liang; Yu Wu
Journal:  World J Surg Oncol       Date:  2013-08-29       Impact factor: 2.754

View more
  8 in total

Review 1.  [Renal cell carcinoma in older and geriatric patients].

Authors:  N Wagener
Journal:  Urologe A       Date:  2017-08       Impact factor: 0.639

2.  Efficacy and feasibility of robot-assisted partial nephrectomy for octogenarians: comparison with younger counterparts.

Authors:  Yudai Ishiyama; Tsunenori Kondo; Kazuhiko Yoshida; Junpei Iizuka; Kazunari Tanabe; Toshio Takagi
Journal:  J Robot Surg       Date:  2022-01-21

3.  DNA Methylation-Based Panel Predicts Survival of Patients With Clear Cell Renal Cell Carcinoma and Its Correlations With Genomic Metrics and Tumor Immune Cell Infiltration.

Authors:  Xiao-Ping Liu; Lingao Ju; Chen Chen; Tongzu Liu; Sheng Li; Xinghuan Wang
Journal:  Front Cell Dev Biol       Date:  2020-10-15

4.  Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Li Tao; Huiyun Zhang; Guangyu An; Haoning Lan; Yaoqi Xu; Yang Ge; Jiannan Yao
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

5.  Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma.

Authors:  Jinkui Wang; Chenghao Zhanghuang; Xiaojun Tan; Tao Mi; Jiayan Liu; Liming Jin; Mujie Li; Zhaoxia Zhang; Dawei He
Journal:  Front Public Health       Date:  2022-01-28

6.  A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Clear Cell Renal Cell Carcinoma: A Population-Based Study.

Authors:  Chenghao Zhanghuang; Jinkui Wang; Zhaoxia Zhang; Liming Jin; Xiaojun Tan; Tao Mi; Jiayan Liu; Mujie Li; Dawei He
Journal:  Front Public Health       Date:  2022-03-03

7.  Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.

Authors:  Chenghao Zhanghuang; Jinkui Wang; Zhigang Yao; Li Li; Yucheng Xie; Haoyu Tang; Kun Zhang; Chengchuang Wu; Zhen Yang; Bing Yan
Journal:  Front Public Health       Date:  2022-04-04

8.  Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.

Authors:  Jinkui Wang; Chenghao Zhanghuang; Xiaojun Tan; Tao Mi; Jiayan Liu; Liming Jin; Mujie Li; Zhaoxia Zhang; Dawei He
Journal:  Front Public Health       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.